Noah Rosenberg
2018
In 2018, Noah Rosenberg earned a total compensation of $2.4M as Chief Medical Officer at Retrophin.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Non-Equity Incentive Plan | $97,750 |
| Option Awards | $1,183,611 |
| Salary | $183,622 |
| Stock Awards | $571,600 |
| Other | $266,500 |
| Total | $2,403,083 |
Rosenberg received $1.2M in option awards, accounting for 49% of the total pay in 2018.
Rosenberg also received $100K in bonus, $97.8K in non-equity incentive plan, $183.6K in salary, $571.6K in stock awards and $266.5K in other compensation.
Rankings
In 2018, Noah Rosenberg's compensation ranked 4,844th out of 14,244 executives tracked by ExecPay. In other words, Rosenberg earned more than 66.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,844 out of 14,244 | 66th |
Division Manufacturing | 1,818 out of 5,759 | 68th |
Major group Chemicals And Allied Products | 661 out of 2,122 | 69th |
Industry group Drugs | 555 out of 1,811 | 69th |
Industry Pharmaceutical Preparations | 428 out of 1,385 | 69th |
Pay ratio
| Noah Rosenberg's Pay | $2,403,083 |
|---|---|
| Median Employee's Pay | $301,797 |
| Pay Ratio | 8to 1 |
In 2018, the annual total compensation of Noah Rosenberg was $2,403,083.
The annual total compensation of the median employee at Retrophin was $301,797.
The ratio of Noah Rosenberg's pay to the pay of median employee was therefore 8 to one.
Source: SEC filing on April 4, 2019.
Rosenberg's colleagues
We found five more compensation records of executives who worked with Noah Rosenberg at Retrophin in 2018.